JAMIE STODD: Open Payments
NPI 1780011981 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 17 payments from 7 companies in 2025. Trend: 2023 $226 · 2024 $482 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $187 |
| Amgen Inc. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Lilly USA, LLC | 1 | $30 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $30 |
| GENZYME CORPORATION | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: TREMFYA, DUPIXENT, OTEZLA, TALTZ, Cabtreo, COSENTYX.
Industry payments across MD — which companies pay providers there.
